tiprankstipranks
Beauty Health (DE:V7A0)
FRANKFURT:V7A0
Germany Market
V7A0
Beauty Health
RESEARCH TOOLSreports

Beauty Health (V7A0) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

V7A0 Analyst Ratings

Moderate Buy
3Ratings
Moderate Buy
1 Buy
2 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Beauty
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

V7A0 Stock 12 Month Forecast

Average Price Target

€1.16
▲(52.93% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Beauty Health in the last 3 months. The average price target is €1.16 with a high forecast of €1.74 and a low forecast of €0.87. The average price target represents a 52.93% change from the last price of €0.76.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","-1":"-€1","-0.25":"-€0.25","0.5":"€0.5","1.25":"€1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.74340556,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€1.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.1622703733333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€1.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.87170278,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€0.87</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.595,0.6833388892307692,0.7716777784615385,0.8600166676923077,0.9483555569230769,1.036694446153846,1.1250333353846154,1.2133722246153846,1.301711113846154,1.3900500030769232,1.4783888923076924,1.5667277815384617,1.6550666707692308,{"y":1.74340556,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.595,0.6386361825641025,0.6822723651282051,0.7259085476923076,0.7695447302564102,0.8131809128205127,0.8568170953846153,0.9004532779487179,0.9440894605128205,0.987725643076923,1.0313618256410255,1.074998008205128,1.1186341907692308,{"y":1.1622703733333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.595,0.6162848292307692,0.6375696584615385,0.6588544876923077,0.6801393169230769,0.7014241461538462,0.7227089753846154,0.7439938046153847,0.7652786338461539,0.7865634630769232,0.8078482923076924,0.8291331215384615,0.8504179507692308,{"y":0.87170278,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.39,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.81,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.31,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.23,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.26,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.18,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.27,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.925,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.805,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.705,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.595,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€1.74Average Price Target€1.16Lowest Price Target€0.87
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on DE:V7A0
George Kelly
Roth MKM
Roth MKM
€2.18→€1.74
Buy
129.40%
Upside
Reiterated
05/20/26
Analysts Conflicted on These Consumer Goods Names: Beauty Health (NASDAQ: SKIN) and JM Smucker (NYSE: SJM)
Canaccord Genuity Analyst forecast on DE:V7A0
Susan Anderson
Canaccord Genuity
Canaccord Genuity
€0.79→€0.87
Hold
14.70%
Upside
Reiterated
05/08/26
Beauty Health (SKIN) Receives a Hold from Canaccord Genuity
TD Cowen Analyst forecast on DE:V7A0
Oliver Chen
TD Cowen
TD Cowen
€1.13→€0.87
Hold
14.70%
Upside
Assigned
05/08/26
Analysts Conflicted on These Consumer Goods Names: Once Upon a Farm, PBC (NYSE: OFRM), Celsius Holdings (NASDAQ: CELH) and Beauty Health (NASDAQ: SKIN)
Stifel Nicolaus Analyst forecast on DE:V7A0
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
€1.74
Hold
129.40%
Upside
Reiterated
03/13/26
Analysts Offer Insights on Consumer Goods Companies: Beauty Health (NASDAQ: SKIN), Dollar General (NYSE: DG) and Campbell Soup (NASDAQ: CPB)
J.P. Morgan Analyst forecast on DE:V7A0
Allen Gong
J.P. Morgan
J.P. Morgan
―
Sell
―
Reiterated
03/13/26
J.P. Morgan Sticks to Their Sell Rating for Beauty Health (SKIN)
Jefferies Analyst forecast on DE:V7A0
Sydney Wagner
Jefferies
Jefferies
€1.39
Hold
83.52%
Upside
Initiated
01/14/26
Beauty Health assumed with a Hold at JefferiesBeauty Health assumed with a Hold at Jefferies
Benchmark Co. Analyst forecast on DE:V7A0
Bruce Jackson
Benchmark Co.
Benchmark Co.
―
Hold
―
Reiterated
11/07/25
Cautious Optimism for Beauty Health Amid Turnaround Efforts and Macroeconomic Challenges
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on DE:V7A0
George Kelly
Roth MKM
Roth MKM
€2.18→€1.74
Buy
129.40%
Upside
Reiterated
05/20/26
Analysts Conflicted on These Consumer Goods Names: Beauty Health (NASDAQ: SKIN) and JM Smucker (NYSE: SJM)
Canaccord Genuity Analyst forecast on DE:V7A0
Susan Anderson
Canaccord Genuity
Canaccord Genuity
€0.79→€0.87
Hold
14.70%
Upside
Reiterated
05/08/26
Beauty Health (SKIN) Receives a Hold from Canaccord Genuity
TD Cowen Analyst forecast on DE:V7A0
Oliver Chen
TD Cowen
TD Cowen
€1.13→€0.87
Hold
14.70%
Upside
Assigned
05/08/26
Analysts Conflicted on These Consumer Goods Names: Once Upon a Farm, PBC (NYSE: OFRM), Celsius Holdings (NASDAQ: CELH) and Beauty Health (NASDAQ: SKIN)
Stifel Nicolaus Analyst forecast on DE:V7A0
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
€1.74
Hold
129.40%
Upside
Reiterated
03/13/26
Analysts Offer Insights on Consumer Goods Companies: Beauty Health (NASDAQ: SKIN), Dollar General (NYSE: DG) and Campbell Soup (NASDAQ: CPB)
J.P. Morgan Analyst forecast on DE:V7A0
Allen Gong
J.P. Morgan
J.P. Morgan
―
Sell
―
Reiterated
03/13/26
J.P. Morgan Sticks to Their Sell Rating for Beauty Health (SKIN)
Jefferies Analyst forecast on DE:V7A0
Sydney Wagner
Jefferies
Jefferies
€1.39
Hold
83.52%
Upside
Initiated
01/14/26
Beauty Health assumed with a Hold at JefferiesBeauty Health assumed with a Hold at Jefferies
Benchmark Co. Analyst forecast on DE:V7A0
Bruce Jackson
Benchmark Co.
Benchmark Co.
―
Hold
―
Reiterated
11/07/25
Cautious Optimism for Beauty Health Amid Turnaround Efforts and Macroeconomic Challenges
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
UTIUniversal Technical Institute
DARDarling Ingredients
CELHCelsius Holdings
KOCoca-Cola
MAMAMama's Creations
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Beauty Health

3 Months
Allen GongJ.P. Morgan
Success Rate
2/6 ratings generated profit
33%
Average Return
-8.72%
Copying Allen Gong's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -8.72% per trade.
1 Year
Allen GongJ.P. Morgan
Success Rate
2/6 ratings generated profit
33%
Average Return
-7.83%
Copying Allen Gong's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -7.83% per trade.
2 Years
Allen GongJ.P. Morgan
Success Rate
2/6 ratings generated profit
33%
Average Return
-7.08%
Copying Allen Gong's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -7.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

V7A0 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
1
1
2
1
Buy
0
0
0
0
0
Hold
2
5
3
6
3
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
2
7
5
9
4
In the current month, V7A0 has received 1 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. V7A0 average Analyst price target in the past 3 months is 1.16.
Each month's total comprises the sum of three months' worth of ratings.

V7A0 Financial Forecast

V7A0 Earnings Forecast

Next quarter’s earnings estimate for V7A0 is -€0.02 with a range of -€0.05 to €0.02. The previous quarter’s EPS was -€0.04. V7A0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year V7A0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for V7A0 is -€0.02 with a range of -€0.05 to €0.02. The previous quarter’s EPS was -€0.04. V7A0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year V7A0 has Performed in-line its overall industry.

V7A0 Sales Forecast

Next quarter’s sales forecast for V7A0 is €63.76M with a range of €61.92M to €65.26M. The previous quarter’s sales results were €55.74M. V7A0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year V7A0 has Performed in-line its overall industry.
Next quarter’s sales forecast for V7A0 is €63.76M with a range of €61.92M to €65.26M. The previous quarter’s sales results were €55.74M. V7A0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year V7A0 has Performed in-line its overall industry.

V7A0 Stock Forecast FAQ

What is DE:V7A0’s average 12-month price target, according to analysts?
Based on analyst ratings, Beauty Health’s 12-month average price target is 1.16.
    What is DE:V7A0’s upside potential, based on the analysts’ average price target?
    Beauty Health has 52.93% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Beauty Health a Buy, Sell or Hold?
          Beauty Health has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Beauty Health’s share price target?
            The average share price target for Beauty Health is 1.16. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €1.74 ,and the lowest forecast is €0.87. The average share price target represents 52.93% Increase from the current price of €0.76.
              What do analysts say about Beauty Health?
              Beauty Health’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of Beauty Health?
                To buy shares of DE:V7A0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.